In CCA cells, JAK2/STAT3 is activated in response to interleukin-6 (IL-6) and is involved in the regulation of cell proliferation and prevention of apoptosis through increased expression of anti-apoptotic genes such as the Bcl-2 family members10. Here, JAK2 is linked to cholangiocarcinoma.